<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01232179</url>
  </required_header>
  <id_info>
    <org_study_id>88100</org_study_id>
    <nct_id>NCT01232179</nct_id>
  </id_info>
  <brief_title>Comparison of Two Laser Therapy Methods for PDR</brief_title>
  <acronym>PDR</acronym>
  <official_title>Comparison Between Result and Side Effects of Treatment of Prolifrative Diabetic Retinopaty by Conventional and Extended Targeted Pan Retinal Photocoagolation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shahid Beheshti University of Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shahid Beheshti University of Medical Sciences</source>
  <brief_summary>
    <textblock>
      Proliferative diabetic retinopathy (PDR) is treated with conventional pan retinal&#xD;
      photocoagulation (PRP) which can improve the visual prognosis in this complication&#xD;
      significantly. However , the treatment may also resulting adverse effects such as blurring of&#xD;
      central vision, visual field constriction and disturbance in dark adaptation and contrast&#xD;
      vision. Extended targeted retinal coagulation (TRP) to the ischemic areas may cause&#xD;
      regression of the neovascularization while minimizing some of the risks and complication&#xD;
      associated of treatment of PDR with these two methods.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2010</start_date>
  <completion_date type="Anticipated">May 2011</completion_date>
  <primary_completion_date type="Anticipated">April 2011</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>no leakage in widefield fluorescin angiography</measure>
    <time_frame>3 months after lasertraphy</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <condition>Proiriftrative Diabetic Retinopathy</condition>
  <arm_group>
    <arm_group_label>conventional prp</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>targeted PRP</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>conventional prp</intervention_name>
    <description>pan retinal photocoagulation</description>
    <arm_group_label>conventional prp</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>targeted prp</intervention_name>
    <description>1200-1600 spot in far periphery retin, anterior equator</description>
    <arm_group_label>targeted PRP</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patients with PDR condidate for photocoagulation teraphy&#xD;
&#xD;
          -  Pupil with dilatasionâ‰¥6mm&#xD;
&#xD;
          -  without privious treatment with anti VEGF drugs 3months before study&#xD;
&#xD;
          -  without privious vitroretinal sugery&#xD;
&#xD;
          -  without privoius lasertraphy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  To have NVI cricteria with increase of inraocular pressure&#xD;
&#xD;
          -  to have cataract or vitrus leakage which prevent lasertraphy&#xD;
&#xD;
          -  pupil smaller that 6mm&#xD;
&#xD;
          -  traditional retinal detachment&#xD;
&#xD;
          -  privious treatment with anti VEGF drugs 3months before study&#xD;
&#xD;
          -  privious PRP&#xD;
&#xD;
          -  patient unable to get wide field FAG&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Labbafinejad medical center</name>
      <address>
        <city>Tehran</city>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Masoud Soheilian, proffesor</last_name>
      <phone>00982122585952</phone>
      <email>masoud_soheilian@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>masoud soheilian, proffesor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Iran, Islamic Republic of</country>
  </location_countries>
  <verification_date>October 2010</verification_date>
  <study_first_submitted>November 1, 2010</study_first_submitted>
  <study_first_submitted_qc>November 1, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 2, 2010</study_first_posted>
  <last_update_submitted>November 1, 2010</last_update_submitted>
  <last_update_submitted_qc>November 1, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 2, 2010</last_update_posted>
  <responsible_party>
    <name_title>Masoud Soheilian</name_title>
    <organization>Ophthalmic Research center</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetic Retinopathy</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

